Ultramicronized Palmitoylethanolamide (um-PEA): A New Possible Adjuvant Treatment in COVID-19 patients
The Coronavirus Disease-19 (COVID-19) pandemic has caused more than 100,000,000 cases of coronavirus infection in the world in just a year, of which there were 2 million deaths. Its clinical picture is characterized by pulmonary involvement that culminates, in the most severe cases, in acute respira...
Saved in:
Main Authors: | Annalisa Noce (Author), Maria Albanese (Author), Giulia Marrone (Author), Manuela Di Lauro (Author), Anna Pietroboni Zaitseva (Author), Daniela Palazzetti (Author), Cristina Guerriero (Author), Agostino Paolino (Author), Giuseppa Pizzenti (Author), Francesca Di Daniele (Author), Annalisa Romani (Author), Cartesio D'Agostini (Author), Andrea Magrini (Author), Nicola Biagio Mercuri (Author), Nicola Di Daniele (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Ultramicronized Palmitoylethanolamide (um-PEA) in COVID-19 Early Stages: A Case-Control Study
by: Maria Albanese, et al.
Published: (2022) -
Cardiovascular Protection of Nephropathic Male Patients by Oral Food Supplements
by: Annalisa Noce, et al.
Published: (2020) -
Corrigendum: Oral ultramicronized palmitoylethanolamide: plasma and tissue levels and spinal antihyperalgesic effect
by: Stefania Petrosino, et al.
Published: (2024) -
Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
by: Stefania Petrosino, et al.
Published: (2018) -
Co-ultramicronized palmitoylethanolamide/luteolin promotes neuronal regeneration after spinal cord injury
by: Rosalia eCrupi, et al.
Published: (2016)